UroToday1d
Clarity and Nucleus RadioPharma Sign Master Services Agreement and Cu-67 SAR-bisPSMA Clinical Supply Agreement
The Master Services Agreement (MSA) and Clinical Supply Agreement with Nucleus RadioPharma complement the existing agreement with NorthStar Medical Radioisotopes, LLC (NorthStar) for 67Cu-SAR-bisPSMA ...
Modern Healthcare1d
The key pillars to building a resilient healthcare supply chain
In this conversation with Medline CEO Jim Boyle, he outlines the strategy health systems need to build a resilient supply ...
Index-Journal2d
SRH partners: Managing IV fluid supply shortage through conservation
As the nation’s largest supplier of intravenous fluids works to return to full production in North Carolina, Self Regional ...
Jupiter Neurosciences, Inc. Prices IPO at $4.00 Per Share (JUNS)
Jupiter Neurosciences, Inc. (JUNS) is planning to raise $11 million in an initial public offering (IPO) on the week of November 11th, IPO Scoop reports. The company plans to issue 2,800,000 shares at ...
Catalent’s Biologics Underperformance and PCH Stability Lead to Hold Rating
Jefferies analyst David Windley maintained a Hold rating on Catalent (CTLT – Research Report) today and set a price target of $63.50.